Gene · 4261
Papers3,496
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,496
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Engineering systemic oncolytic virotherapy through immune-compatible delivery and programmable tumor cell death. | Mol Ther Oncol | 2026 | 41736769 | PubTator, text mining | PubMed |
| Advances in Engineered Virus-Like Particles for Genome Editing and Therapy. | BioDrugs | 2026 | 41733889 | PubTator, text mining | PubMed |
| Discover personalized drug opportunity and optimized tumor-infiltrating lymphocyte therapy for rare cancer: an organoid-based whole-journey clinical mapping study in a neuroendocrine cancer patient. | Cell Oncol (Dordr) | 2026 | 41733805 | PubTator, text mining | PubMed |
| Targeting pyroptosis in periodontitis: mechanisms and therapeutic strategies. | Front Immunol | 2026 | 41727505 | PubTator, text mining | PubMed |
| The tumor microenvironment in leukemia: molecular pathways of immune evasion. | Front Immunol | 2026 | 41727472 | PubTator, text mining | PubMed |
| Cancer-associated fibroblasts are associated with CD8+ T cell depletion and poor prognosis in colorectal adenocarcinoma: a multi-omics and machine learning analysis. | J Pathol Clin Res | 2026 | 41725109 | PubTator, text mining | PubMed |
| Monocytes acquire a tumor-associated IL1B program upon encountering patient-derived colon cancer organoids. | Oncoimmunology | 2026 | 41723598 | PubTator, text mining | PubMed |
| The immunopathological crosstalk of diabetic periodontitis: Single-cell insights into monocyte dysregulation. | PLoS One | 2026 | 41701724 | PubTator, text mining | PubMed |
| Unraveling Signaling Pathways in Immune Microenvironment Crosstalk to Overcome Immunotherapy Resistance in Colorectal Cancer. | Hum Mutat | 2026 | 41693728 | PubTator, text mining | PubMed |
| Activin-A has dual roles in osteoclast formation and foreign body giant cell differentiation from human CD14+ monocytes. | Bone | 2026 | 41643827 | PubTator, text mining | PubMed |
| Multiomic analysis of colorectal adenocarcinoma reveals a new subtype of myofibroblastic cancer-associated fibroblasts that express high levels of B7-H3 and have poor-prognosis value. | J Immunother Cancer | 2026 | 41629132 | PubTator, text mining | PubMed |
| Interaction between HIV-1 Tat and EBV Zta favours immune escape of B cells by downregulating HLA-ABC expression. | Cell Mol Life Sci | 2026 | 41627500 | PubTator, text mining | PubMed |
| POSTN⁺ cancer-associated fibroblast-CCL3⁺ macrophage crosstalk defines the immune-excluded tumor microenvironment in clear cell renal cell carcinoma. | Transl Oncol | 2026 | 41579565 | PubTator, text mining | PubMed |
| Multi-scale transcriptomics analysis reveals MHC suppression in MEF2D fusion positive B-cell acute lymphoblastic leukemia. | Biochem Biophys Res Commun | 2026 | 41547299 | PubTator, text mining | PubMed |
| The role of MHC molecules in cancer immunotherapy: Insights into tumor immune evasion and therapeutic strategies. | Crit Rev Oncol Hematol | 2026 | 41320145 | PubTator, text mining | PubMed |
| Retinoic Acid Reprograms Mast Cells Toward a Proinflammatory State to Enhance Antitumor Immunity. | Adv Sci (Weinh) | 2026 | 41309490 | PubTator, text mining | PubMed |
| Enhanced antigen presentation by macrophages promotes human atherosclerosis progression: therapeutic implications. | Eur Heart J | 2026 | 41217874 | PubTator, text mining | PubMed |
| Monogenic Contributions to Familial Endometriosis: A Scoping Review. | Gynecol Obstet Invest | 2026 | 41201978 | PubTator, text mining | PubMed |
| A differentiated and durable allogeneic strategy applicable to cell therapies. | Cytotherapy | 2026 | 41201433 | PubTator, text mining | PubMed |
Normothermic Machine Perfusion Combined With Modified Small Interfering RNA Targeting Beta-2-microglobulin and Class II Major Histocompatibility Complex Transactivator Mitigates Acute Rejection of Renal Allograft. | Transplantation | 2026 | 41145403 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4261/papers?page=3